Latest News
-
Friday - July 4, 2008
Flexible track superstructure system with polyurethane proves its worth in rail traffic
Noise protection through foamed track ballast layer
Less noise pollution for residents / Extended maintenance cycles for track sections / Great potential for applications in local and long-distance traffic
-
Thursday - July 3, 2008
Bayer CropScience strengthens global position in insecticides market:
Insecticide Movento® approved in United States and Canada
Launch of Movento® planned for 2008
-
Thursday - July 3, 2008
Human gene recreated using transparent, high-tech plastic:
Makrolon® forges links between art and medicine
Foyer of Klinikum Bamberg now home to “Chromosom”, a four-meter-high sculpture made of CDs
-
Wednesday - July 2, 2008
Bayer HealthCare Completes Acquisition of Western OTC Cough and Cold Business of Topsun Science and Technology
Significantly Strengthens Consumer Care Division’s Business in High Growth Chinese OTC Market
-
Wednesday - July 2, 2008
Bayer Expands Hemophilia Portfolio
Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen
Phase 1 clinical testing expected to commence in third quarter of 2008 / Transaction includes license to Maxygen’s novel biotechnology research platform
-
Monday - June 30, 2008
Venous Blood Clot Prevention after Knee and Hip Replacement Surgery:
Rivaroxaban is First Novel Oral Anticoagulant to Significantly Reduce the Composite Outcome of Symptomatic VTE and Death
Rivaroxaban shows superior efficacy to enoxaparin for this clinical outcome with a comparable safety profile / Pre-specified analysis of pooled data from RECORD 1-3 studies involving nearly 10,000 patients
-
Friday - June 27, 2008
Bayer at a glance:
New edition of “Names, Figures, Facts”
Service line for free booklet
-
Thursday - June 26, 2008
Venous Blood Clot Prevention after Total Hip and Knee Replacement Surgery:
New England Journal of Medicine Publishes Results from Two of the Landmark Phase III RECORD Studies with Rivaroxaban
Head-to-Head trials involving over 7000 patients after Major Orthopedic Surgery / Rivaroxaban superior to Enoxaparin in Preventing Venous Blood Clots / Bleeding rates were low and comparable between the treatment arms
-
Wednesday - June 25, 2008
Venous Blood Clot Prevention after Hip Replacement Surgery:
The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2
Trial involving over 2.500 patients after hip replacement surgery / Five weeks of Rivaroxaban compared to two weeks enoxaparin / Extended Rivaroxaban treatment regimen significantly more effective with comparable low bleeding rates
-
Tuesday - June 24, 2008
Bayer MaterialScience at EuroLITE 2008
2. International Trade Fair for Lightweight Design, at the exhibition center of Salzburg (Austria) from June 24 - 26, 2008
-
Tuesday - June 24, 2008
Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States
Appeal of court decision invalidating Yasmin patent will continue / Further growth of Bayer’s Women’s Healthcare Business Unit expected
-
Monday - June 23, 2008
Bayer’s Belford Roxo site near Rio de Janeiro celebrates 50th anniversary of its founding
Bayer plans to invest EUR 100 million in Brazil
Wenning: “Brazil is our biggest market in Latin America”
-
Monday - June 23, 2008
New Bayer technology reduces power consumption and CO2 emissions by 30 percent:
Bayer receives Environmental Award from the Federation of German Industries
Energy-efficient process recycles chlorine from hydrochloric acid / Industrial application in Germany and China / Bayer Management Board member Dr. Plischke: “Increase in energy efficiency brings economic and ecological benefits”
-
Friday - June 20, 2008
In recognition of contributions to German-American economic relations
Bayer CEO Werner Wenning receives prestigious McCloy Award
Former German Foreign Minister Hans-Dietrich Genscher presents the honor in New York
-
Friday - June 20, 2008
Bayer MaterialScience raises prices for polycarbonates
-
Thursday - June 19, 2008
Makrofol® ID for security cards:
40 million driving licenses for the United Kingdom
Excellent counterfeit protection
-
Thursday - June 19, 2008
Bayer MaterialScience and Ertisa conclude agreement on phenol and acetone supply
-
Monday - June 16, 2008
Inauguration of Bayer’s pilot facility for the “production of medicinal products in tobacco plants”
Halle, Germany
-
Monday - June 16, 2008
Bayer CropScience opens rice research laboratory in Singapore
Investment of EUR 5 million to support development of new rice varieties for the Asian market
-
Thursday - June 12, 2008
Bayer MaterialScience raises price for MDI
Search
Publications
Annual Report 2007
Stockholder's Newsletter
research – The Bayer Scientific Magazine
Sustainable Development Report 2007
Publications Overview
Newsletter
Events
Download Center - Selection
